...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Debt

"I see no reason why they would do a buyout now. "

well then next time you see donny tell him to keep his fricking mouth shut!! 

Share
New Message
Please login to post a reply